000 01284 a2200325 4500
005 20250512031408.0
264 0 _c19860620
008 198606s 0 0 eng d
022 _a0022-2623
024 7 _a10.1021/jm00155a048
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBotros, S
245 0 0 _aInvestigation of the structural requirements for the kappa-selective opioid receptor antagonist, 6 beta,6 beta'-[ethylenebis(oxyethyleneimino)]bis[17-(cyclopropylmethyl)- 4,5 alpha-epoxymorphinan-3,14-diol] (TENA).
_h[electronic resource]
260 _bJournal of medicinal chemistry
_cMay 1986
300 _a874-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aElectric Stimulation
650 0 4 _aGuinea Pigs
650 0 4 _aIleum
_xdrug effects
650 0 4 _aMorphine
_xpharmacology
650 0 4 _aNaltrexone
_xanalogs & derivatives
650 0 4 _aReceptors, Opioid
_xmetabolism
650 0 4 _aStructure-Activity Relationship
700 1 _aLipkowski, A W
700 1 _aTakemori, A E
700 1 _aPortoghese, P S
773 0 _tJournal of medicinal chemistry
_gvol. 29
_gno. 5
_gp. 874-6
856 4 0 _uhttps://doi.org/10.1021/jm00155a048
_zAvailable from publisher's website
999 _c3015633
_d3015633